Account
The Hype Studio bags the PR Mandate of Santaan IVF
Mumbai – Hype Studio, a leading PR agency known for its interactive expertise, is excited to announce its latest achievement – securing a PR commission for Santan IVF, a pioneer in fertility treatments
Santaan IVF, a trusted name in the reproductive healthcare industry, has been building PR efforts to increase brand awareness and communication with The Hype Studio Hype Studio’s proven track record of success in the industry, which is credited ho with their innovative and customized PR strategies, made them a natural choice for IVF.
This collaboration is an important milestone for Santan IVF as they aim to increase their brand presence and share their commitment to providing superior fertility solutions. Known for its human-centric approach to public relations, Hype Studio is moving away from AI-generated content to focus on authentic, human content to connect with its target audience emotionally.
In a statement, Santan’ IVF CEO Raghab Panda enthused about the partnership, “We believe that The Hype Studio’s expertise in producing compelling content plays a vital role in our mission to reach a wider audience.” of the community. Their commitment to human-centered communication seamlessly aligns with our values.” and we have a reward.” We look forward to cooperating.”
Hype Studio has demonstrated its prowess in PR through successful partnerships with various respected agencies in the past. Their recent partnerships has attracted a lot of attention, re-establishing The Hype Studio as a force to be reckoned with in the PR landscape
The Hype Studio director Vineet Malhotra said, “We are honored to be chosen as our PR partner for Santan IVF. Our team is dedicated to using our experience and creativity to drive the story of Santan IVF.” encourage, build an emotional connection with the audience.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
